Alprazolam Powder Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Alprazolam Powder Market is Segmented by Formulation Type (Extended Release Tablet and Orally Disintegrating Tablet), Application (Panic Disorders, Anxiety, Depression, Insomnia, and Other Applications), End-User (Research Institutes and Pharmaceutical Companies), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The report offers the value (USD) for the above segments.

Alprazolam Powder Market Size

Alprazolam Powder Market Summary
share button
Study Period 2018-2028
Base Year For Estimation 2022
CAGR 5.30 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Alprazolam Powder Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Alprazolam Powder Market Analysis

The alprazolam powder market is expected to register a CAGR of 5.3% over the forecast period.

  • COVID-19 significantly impacted the Alprazolam market since the key manufacturers witnessed a supply shortage for product manufacturing which further led to supply chain disruption across the globe. However, the abrupt changes in people's lifestyles brought on by the lockdown contributed to anxiety and depression. 
  • According to an article published in October 2021 in the Journal of the American Medical Association (JAMA) Network, due to the effects of the immediate lockdown, a sharp increase in the utilization of benzodiazepines like alprazolam was reported among the United States population. Such demand increases were unexpected and of great magnitude, exceeding the capacity of manufacturers to maintain adequate supply levels of these pharmaceuticals, which further put the manufacturers under more stress during the pandemic. 
  • However, as the pandemic restrictions are eased, the market is expected to grow significantly due to the rise in mental health problems and the increase in the adoption of alprazolam products for mental health issues.
  • Factors such as an increase in the prevalence of mental illnesses such as depression, and anxiety, a rise in awareness programs to undergo treatment for mental health issues coupled with the surge in research and development activities to develop alprazolam products are expected to bolster the market growth over the study period. 
  • For instance, according to the March 2023 update by the World Health Organization (WHO), an estimated 3.8% of people in the global population suffer from depression, including 5.7% of those over 60 and 5% of adults (4% of males and 6% of women). Women are around 50% more likely than males to experience depression. 
  • Similarly, according to the Census Bureau's Household Pulse Survey, half (50%) of individuals between 18 and 24 reported witnessing anxiety or depression in 2023, compared to around a third of all adults. The results also indicated that young adults are more susceptible to mental health issues than individuals in any other age group. Thus, owing to the high prevalence of anxiety and depression, the demand for alprazolam products is likely to increase, driving the market growth for alprazolam powder over the study period.
  • Furthermore, the presence of key players, their strategic product launches, and increased research activities demonstrating the benefit offered by Alprazolam are expected to bolster market growth.
  •  For instance, in December 2022, UCB Biopharma SRL sponsored a clinical study to evaluate the relative bioavailability of alprazolam in plasma following a single dose of Staccato alprazolam compared to a single dose of oral alprazolam under fasted conditions. 
  • Similarly, according to an article published in March 2023 in Taylor and Francis Online, following the failure of the initial therapy for generalized anxiety disorder, some benzodiazepines (alprazolam, bromazepam, diazepam, and lorazepam) were recommended if the patient doesn't have a history of a drug misuse issue.
  • Thus, the high prevalence of mental health diseases and the rise in the adoption of alprazolam products for treating anxiety is expected to bolster the market growth. However, the side effect associated with alprazolam products and the stringent regulatory framework for product approvals is likely to hinder the market growth over the forecast period.

Alprazolam Powder Market Trends

Anxiety Segment is Expected to Witness a Positive Growth Over the Forecast Period

  • Anxiety is a state of intense, excessive, and persistent worry and fears about the situations currently occurring in a person's life. Anxiety can be common under demanding circumstances, such as giving a public speech or taking an exam. When anxiety becomes enormous, overwhelming, and interferes with everyday life, it is merely a sign of an underlying illness.
  • The increase in cases of anxiety is expected to raise the demand for alprazolam products and thereby boost segment growth over the forecast period. For instance, according to Mental Health Foundation, in 2022-2023, an average of 37.1% of women and 29.9% of men reported high anxiety levels in the United Kingdom.
  • Furthermore, an increase in government initiatives and campaigns to educate the public regarding the importance of mental health is expected to bolster the segment growth over the study period. For instance, in October 2022, the Pan American Health Organization (PAHO) launched #DoYourShare to support mental health, a campaign that seeks to cure the stigma and discrimination experienced by people with mental health conditions and promote positive interactions that improve their search for help.
  • Similarly, in October 2022, Harvard launched a campus-wide mental health awareness campaign and new student wellness resources. The University's campaign was officially begun with the launch of the online learning module. Thus, such awareness campaigns are expected to educate people to come out of their hesitation to take medication for mental illness and promote treatment for anxiety, thereby expected to bolster the segment growth over the study period.
  • Thus, owing to the increase in anxiety cases, and the rise in government initiatives to educate people regarding the importance of treating anxiety, the studied segment is expected to witness significant growth over the forecast period.
Alprazolam Powder Market - Research Funding for Mental Illness (in USD Billion), United States, 2022-2024

North America is Expected to Witness a Significant Growth Over the Forecast Period

  • North America is expected to witness significant market growth owing to better healthcare infrastructure, high awareness, and the presence of major industry players. Moreover, an increase in the prevalence of mental disorders is further expected to bolster market growth. For instance, according to the reports published by Mental Health America in 2023, the prevalence of mental illness ranked 1 in Kentucky in 2022. 
  • In addition, 15.35% of adults in America reported having a substance use disorder, 6.82% reported an illicit drug use disorder, and 10.96% of adults reported alcohol use disorder in 2022. The state prevalence of adult mental illness ranges from 17.49% in Florida to 29.68% in Utah in 2022. 
  • Similarly, according to Canadian Institute for Health Information (CIHI), 3 out of 5 children and youth (age 12 to 24) with self-reported early needs accessed mental health and substance use services in Canada. The high prevalence of mental health diseases is expected to raise the demand for alprazolam powder to manufacture more alprazolam products in North America.
  • Furthermore, an increase in research funding for developing mental health treatment products is expected to bolster the market growth in North America over the study period. For instance, in March 2022, Texas Health and Human Services launched a USD 23.2 million public awareness campaign to prevent substance use disorders and help the public to access necessary treatment and services.
  • Thus, due to the increase in mental health diseases and government funding for treating mental illness, North America is expected to witness significant growth over the forecast period.
Alprazolam Powder Market - Growth Rate by Region

Alprazolam Powder Industry Overview

The Alprazolam powder market is moderately competitive in nature due to the presence of a few companies operating globally as well as regionally. Also, the companies continuously engage in various strategical activities to increase product availability across the regions. A few of the major companies in the market are Taj Pharmaceuticals Limited, Novartis AG (Sandoz), Pfizer Inc., Terrace Pharmaceuticals Ltd, and AdvaCare Pharma, among others.

Alprazolam Powder Market Leaders

  1. Taj Pharmaceuticals Limited

  2. AdvaCare Pharma

  3. Novartis AG (Sandoz)

  4. Pfizer Inc.

  5. Terrace Pharmaceuticals Ltd.

*Disclaimer: Major Players sorted in no particular order

Alprazolam Powder Market Concentration

Alprazolam Powder Market News

  • May 2023: UCSF Benioff Children's Hospital Oakland opened its first stand-alone outpatient mental health services building dedicated to children and youth as part of its ongoing efforts to address the rising need for pediatric mental health services in Oakland and the region.
  • May 2023: The National Alliance on Mental Illness (NAMI) launched #MoreThanEnough, an empowering campaign for 2023 Mental Health Awareness Month. In light of the ongoing mental health crisis, #MoreThanEnough highlighted people's inherent worth and capacity for full lives while highlighting tools and gatherings that foster community and support.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 The Growing Burden of Mental illness

      2. 4.2.2 Rise in Awareness Programs Regarding Mental Health

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Framework and Adverse Effect of Alprazolam Products

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 By Formulation Type

      1. 5.1.1 Extended Release Tablet

      2. 5.1.2 Orally Disintegrating Tablet

    2. 5.2 By Application

      1. 5.2.1 Panic Disorders

      2. 5.2.2 Anxiety

      3. 5.2.3 Depression

      4. 5.2.4 Insomnia

      5. 5.2.5 Other Applications

    3. 5.3 By End-User

      1. 5.3.1 Research Institutes

      2. 5.3.2 Pharmaceutical Companies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Rest of the World


    1. 6.1 Company Profiles

      1. 6.1.1 Taj Pharmaceuticals Limited

      2. 6.1.2 AdvaCare Pharma

      3. 6.1.3 Novartis AG (Sandoz)

      4. 6.1.4 Pfizer Inc.

      5. 6.1.5 Terrace Pharmaceuticals Ltd.

      6. 6.1.6 Torrent Pharmaceuticals Ltd.

      7. 6.1.7 Lifecare Neuro Products Ltd

      8. 6.1.8 Cadila Pharmaceuticals

      9. 6.1.9 Marsha Pharma Private Limited

      10. 6.1.10 Sun Pharmaceutical Industries Ltd.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Alprazolam Powder Industry Segmentation

As per the scope of the report, Alprazolam is a strong, rapidly acting benzodiazepine that has a relaxing effect on the central nervous system. Alprazolam is widely utilized for treating anxiety and panic disorders. 

The alprazolam powder market is segmented by formulation type (extended release tablet and orally disintegrating tablet), application (panic disorders, anxiety, depression, insomnia, other applications), end-user (research institutes and pharmaceutical companies), geography (North America, Europe, Asia-Pacific, and Rest of the World). 

The report offers the value (USD) for the above segments.

By Formulation Type
Extended Release Tablet
Orally Disintegrating Tablet
By Application
Panic Disorders
Other Applications
By End-User
Research Institutes
Pharmaceutical Companies
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Rest of the World

Report scope can be customized per your requirements. Click here.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Alprazolam Powder Market is studied from 2018 - 2028.

The Alprazolam Powder Market is growing at a CAGR of 5.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2018-2028.

North America holds highest share in 2022.

Taj Pharmaceuticals Limited, AdvaCare Pharma, Novartis AG (Sandoz), Pfizer Inc., Terrace Pharmaceuticals Ltd. are the major companies operating in Alprazolam Powder Market.

Alprazolam Powder Industry Report

Statistics for the 2023 Alprazolam Powder market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Alprazolam Powder analysis includes a market forecast outlook to for 2023 to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!